Gastric Ischemic Preconditioning Before Esophagectomy
Active, not recruiting
- Conditions
- Embolization of the Left Gastric Artery Prior to SurgeryOperable Esophageal Cancer
- Registration Number
- NCT06453031
- Lead Sponsor
- CHU Rennes - Hopital Pontchaillou
- Brief Summary
The aim of the study is to investigate the impact of left gastric artery embolization before esophagectomy on postoperative complications, particularly anastomotic leaks and necrosis of the gastric conduit.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Patient with operable esophageal cancer who underwent embolization of the left gastric artery prior to surgery.
Exclusion Criteria
Patient with no operable esophageal cancer
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Gastric conduit necrosis 6 months Anastomotic leak 6 months Anastomotic stenosis 6 months
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie gastric ischemic preconditioning in esophagectomy patients?
How does preoperative embolization of the left gastric artery compare to standard-of-care in reducing anastomotic leaks?
What biomarkers predict response to gastric ischemic preconditioning in operable esophageal cancer?
What are the potential adverse events associated with left gastric artery embolization before esophagectomy?
Are there combination approaches involving gastric ischemic preconditioning and other therapies for esophageal cancer?
Trial Locations
- Locations (1)
Livin
🇫🇷Rennes, Bretagne, France
Livin🇫🇷Rennes, Bretagne, France